Plus Therapeutics (PSTV) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Plus Therapeutics (PSTV) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-16.86% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Plus Therapeutics |
34.26 Mn |
19.15 Mn |
- |
-128.20% |
| Date | Value |
|---|
| Mar 31, 2026 |
-128.20% |
| Mar 31, 2025 |
31.22% |
| Dec 31, 2024 |
-49.41% |
| Sep 30, 2024 |
-52.69% |
| Jun 30, 2024 |
-119.91% |
| Mar 31, 2024 |
-113.03% |
| Dec 31, 2023 |
-54.19% |
| Sep 30, 2023 |
-100.25% |
| Jun 30, 2023 |
-12.54% |
| Mar 31, 2023 |
-71.43% |
| Dec 31, 2022 |
-104.68% |
| Sep 30, 2022 |
-76.29% |
| Jun 30, 2022 |
-105.04% |
| Mar 31, 2022 |
-67.68% |
| Dec 31, 2021 |
-80.00% |
| Sep 30, 2021 |
-59.14% |
| Jun 30, 2021 |
-45.76% |
| Mar 31, 2021 |
0.82% |
| Dec 31, 2020 |
-27.77% |
| Sep 30, 2020 |
20.22% |
